Skip to main content
Livermore
Livermore
ZHEN

IFP Advisors, Inc

SEC CIK
0001641866
Latest filing
Jul 20, 2026

INO holding history

Inovio Pharmaceuticals, Inc. in every 13F filed by IFP Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INO overviewAll 13F holders of INOFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of INO by IFP Advisors, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−14−100.0%Sold outHolders
Q4 202514$24<0.1%00.0%UnchangedHolders
Q3 202514$33<0.1%00.0%UnchangedHolders
Q2 202514$28<0.1%+14AddedHolders
Q1 20250$118<0.1%0UnchangedHolders
Q4 20240$134<0.1%−14−100.0%ReducedHolders
Q3 202414$81<0.1%00.0%UnchangedHolders
Q2 202414$113<0.1%−175−92.6%ReducedHolders
Q1 2024189$2.62K<0.1%+126+201.6%AddedConverted for a 1-for-12 splitHolders
Q4 2023752$383<0.1%00.0%UnchangedHolders
Q3 2023752$292<0.1%00.0%UnchangedHolders
Q2 2023752––+342+83.4%AddedHolders
Q1 2023410––−5,853−93.5%ReducedHolders
Q4 20226,263$29.0K<0.1%+1,000+19.0%AddedHolders
Q3 20225,263$25.0K<0.1%+2,963+128.8%AddedHolders
Q2 20222,300$11.0K<0.1%−510−18.1%ReducedHolders
Q1 20222,810$14.0K<0.1%+2,300+451.0%AddedHolders
Q4 2021510$3.00K<0.1%−450−46.9%ReducedHolders
Q3 2021960$7.00K<0.1%−12,158−92.7%ReducedHolders
Q2 202113,118$122.0K<0.1%+11,192+581.1%AddedHolders
Q1 20211,926$18.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.